Genetic Technologies (GENE) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Genetic Technologies has successfully secured a $2 million investment through a private placement of shares to sophisticated US investors, facilitated by HCW Wainwright & Co. The placement occurred without the need for public disclosure in compliance with the Corporations Act, indicating the company’s adherence to regulatory requirements.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.